![2023 International Mental Health Research Symposium Presentations 2023 International Mental Health Research Symposium Presentations](/sites/default/files/styles/blog_thumbnail/public/images/blog/teaser/website-symposium-2023.jpeg?itok=3Xz8wx8k)
On October 27, 2023, we held our International Mental Health Research Symposium.
Read More![A RESEARCHER’S PERSPECTIVE: What Genetics Is Telling Us About Substance Use Disorders A RESEARCHER’S PERSPECTIVE: What Genetics Is Telling Us About Substance Use Disorders](/sites/default/files/styles/blog_thumbnail/public/images/blog/teaser/GeneticsGenomesSubtanceAbuse-1440.jpg?itok=3HceuWuL)
Dr. Sandra Sanchez-Roige explains how large-scale studies of genome variations have identified risk locations for substance use disorders. She also discusses the importance of converting these signals from the genome into biological understanding of mechanisms and vulnerabilities which may provide a path forward for the development of novel treatments.
Read More![On Fentanyl, the Opioid Crisis, Psychedelics, and Cannabis Risk: A Q&A with Dr. Nora Volkow On Fentanyl, the Opioid Crisis, Psychedelics, and Cannabis Risk: A Q&A with Dr. Nora Volkow](/sites/default/files/styles/blog_thumbnail/public/images/blog/teaser/NoraVolkowOpioidCrisisBanner.jpg?itok=dbn7Vxbp)
Dr. Volkow, Director of the National Institute on Drug Abuse (NIDA) and leading authority on substance use and the science of addiction, explains the origins of the fentanyl crisis, the challenges of treating overdoses, and offers her assessment of psychedelics as therapies for psychiatric illness, as well as current evidence on the dangers of regular cannabis use among young people.
Read More![ECT, MST, and Other Neuromodulation Therapies to Relieve Severe Psychiatric Illness ECT, MST, and Other Neuromodulation Therapies to Relieve Severe Psychiatric Illness](/sites/default/files/styles/blog_thumbnail/public/images/blog/teaser/ManDepressedAgainstWall-1440.jpg?itok=5iTJF71r)
Dr. Sarah Lisanby has been deeply involved in developing and improving the safety of life-saving neuromodulatory treatments including electroconvulsive therapy (ECT) and magnetic seizure therapy (MST) for severe psychiatric illness.
Read More![2023 Leading Research Achievements 2023 Leading Research Achievements](/sites/default/files/styles/blog_thumbnail/public/images/blog/teaser/ScientificAbstractBrainCells-1440.jpg?itok=54JEdH0r)
We are pleased to present you with the 2023 Leading Research Achievements by BBRF Grantees, Prize Winners & Scientific Council Members.
Read More